Abstract: The present disclosure provides methods and compositions comprising hyaluronic acid (HA) hydrogel in combination with a saturated fatty acid for treating osteoarthritis. In some embodiments, aspects of the disclosure relate to pharmaceutical compositions comprising HA hydrogel in combination with a steroid. In some embodiments, the pharmaceutical compositions may be administrable via local, topical, and injection. In some embodiments, the pharmaceutical composition may be administrable by intra-articular injection.
Type:
Application
Filed:
January 26, 2024
Publication date:
August 1, 2024
Applicant:
INSIGNIA PHARMACEUTICALS, LLC
Inventors:
David BAR-OR, Gregory THOMAS, Melissa HAUSBURG, Jason WILLIAMS, Raphael BAR-OR